Cosara Diagnostics Pvt. Ltd. was incorporated in 2017 based on a joint venture agreement between Synbiotics Limited and Co-Diagnostics, Inc. USA, The vision of the company is to bring high quality molecular diagnostic products globally to reduce cost and provide exceptional products to meet the market needs.
Cosara complies with all the Quality Management Systems required by the Central Drugs Standard Control Organisation (CDSCO). Our 30,000 sq. ft, Good Manufacturing Practices (GMP) facility proudly incorporated in India with a focus on innovation and expertise, Cosara is committed to meeting the growing needs of patients worldwide who need immediate access to critical molecular diagnostic tests.